Previous close | 1.8000 |
Open | 1.8000 |
Bid | 0.0000 |
Ask | 5.0000 |
Strike | 85.00 |
Expiry date | 2024-05-17 |
Day's range | 1.8000 - 1.8000 |
Contract range | N/A |
Volume | |
Open interest | 31 |
Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today reported financial results for the first quarter ended March 31, 2024, and provided a review of recent accomplishments and anticipated upcoming developments.
Those following along with Biohaven Ltd. ( NYSE:BHVN ) will no doubt be intrigued by the recent purchase of shares by...
On April 24, 2024, Gregory Bailey, Director of Biohaven Ltd (NYSE:BHVN), purchased 25,503 shares of the company, as reported in a recent SEC Filing.